Further studies are therefore needed to confirm these current findings, and to determine whether CRP might be indeed more useful as an early detection or prognostic marker in BD or at least used as a part of a composite-biomarker, or might be suitable as a biomarker for distinguishing inflammatory subgroups. This evidence concerns the gene CRP and Behcet disease.